Development of camelid single chain antibodies against Shiga toxin type 2 (Stx2) with therapeutic potential against Hemolytic Uremic Syndrome (HUS)

Shiga toxin (Stx)-producing Escherichia coli (STEC) infections are implicated in the development of the life-threatening Hemolytic Uremic Syndrome (HUS). Despite the magnitude of the social and economic problems caused by STEC infections, no licensed vaccine or effective therapy is presently availab...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Sci Rep
Autors principals: Mejías, Maria P., Hiriart, Yanina, Lauché, Constanza, Fernández-Brando, Romina J., Pardo, Romina, Bruballa, Andrea, Ramos, María V., Goldbaum, Fernando A., Palermo, Marina S., Zylberman, Vanesa
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2016
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4847011/
https://ncbi.nlm.nih.gov/pubmed/27118524
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep24913
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars